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In vitro signiicance of SOCS-3 and 
SOCS-4 and potential mechanistic 
links to wound healing
Yi Feng1, Andrew J. Sanders1, Liam D. Morgan1, Sioned Owen1, Fiona Ruge1,2, Keith G. 
Harding2 & Wen G. Jiang1
Wound healing and the management of chronic wounds represent a signiicant burden on the NHS. 
Members of the suppressor of cytokine signalling (SOCS) family have been implicated in the regulation 
of a range of cellular processes. The current study aims to explore the importance of SOCS-3 and 
SOCS-4 in regulating cellular traits associated with wound healing. SOCS-3 over-expression and 
SOCS-4 knockdown mutant lines were generated and veriied using q-PCR and western blotting in 
human keratinocytes (HaCaT) and endothelial cells (HECV). Over-expression of SOCS-3 resulted in a 
signiicantly reduced proliferative rate in HaCaT keratinocytes and also enhanced the tubule formation 
capacity of HECV cells. SOCS-4 knockdown signiicantly reduced HaCaT migration and HECV cell tubule 
formation. Suppression of SOCS-4 inluenced the responsiveness of HaCaT and HECV cells to EGF and 
TGFβ and resulted in a dysregulation of phospho-protein expression in HaCaT cells. SOCS-3 and SOCS-4 
appear to play regulatory roles in a number of keratinocyte and endothelial cellular traits associated 
with the wound healing process and may also be able to regulate the responsiveness of these cells to 
EGF and TGFβ. This implies a potential regulatory role in the wound healing process and, thus highlights 
their potential as novel therapies.
Chronic wounds are deined as wounds that fail to follow the orderly and timely reparative process seen in normal 
healing, which in turn disrupts the anatomic and functional integrity of the wound site1. Chronic wounds have 
been considered to be a signiicant medical burden to the general public healthcare system both in terms of cost 
and resources2.
here are many types of chronic wounds with the majority being categorised into four subtypes, pressure 
ulcers, arterial and venous ulcers as well as diabetic ulcers, which have diverse aetiologies3, 4. Venous ulceration 
is one of the most common lower extremity ulcerations, requiring long-term care, displaying high recurrence 
rates and accounting for a substantial amount of healthcare budgets worldwide5, 6. Diabetic foot ulcers also con-
tribute to the signiicant medical burden, not only through the considerable expenditure on diabetic foot and 
amputation care, but also through the negative impact associated with high morbidity and mortality rates7. Many 
medical treatment strategies and guidelines have been developed and are evolving to make the management of 
chronic wounds more eicient and cost efective, however, the implementation of such strategies still remains 
challenging and are limited to certain types of disease6, 7. To date, the molecular mechanisms involved in chronic 
wound formation still remain unclear due to the complexity of the wound healing process and the diverse aeti-
ologies of diferent types of chronic wounds. herefore, investigations into the cellular impact of key molecules 
in fundamental cell types involved in the wound healing process and further examination of potential upstream 
and downstream mechanisms involved, are essential for the generation of bio- or prognostic markers and new 
therapeutic strategies to combat and aid in the management of chronic wounds.
Wound healing is a sophisticated biological process in which a variety of cell types synergistically coordinate 
to regenerate functional new skin tissue. Numerous cytokines and growth factors are derived from these cells and 
regulate signalling cascades which contribute to wound closure. However, dysregulation of cytokine signalling 
can lead to abnormalities in cellular functions, extended healing times and impairment of the normal healing 
process, inally leading to non-healing chronicity8. Suppressor of cytokine signalling (SOCS) proteins have been 
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recognised as classic cytokine-inducible negative feedback inhibitors9. Once synthesised, SOCS proteins act to 
target and deactivate the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, a 
common pathway utilised in cytokine signalling. his is via i) inhibition of JAK tyrosine kinase activity through 
binding to the activated JAK protein; ii) competing with STAT for the cytokine receptor docking site; iii) promot-
ing the proteasomal degradation of SOCS-target protein complex10, ensuring that JAK/STAT cytokine signalling 
is only maintained for an appropriate amount of time. Hence, SOCS can act as an ‘automatic switch’ to control the 
homeostasis of activated cytokine or growth factor signalling. SOCS proteins are a family of intracellular proteins 
containing eight members11. Several members of the SOCS family have been extensively studied in diferent areas 
of research and have been discovered to be able to regulate a wide variety of cytokines and growth factors which 
play key roles in the wound healing process12.
SOCS-3 is one of the most extensively studied SOCS family members. A previous in vivo study has indicated 
that knockdown of SOCS-3 in epithelial basal keratinocytes contributes to severe skin inlammation, indicating 
an important role in skin homeostasis13. However, over-expression of SOCS-3 has also been shown to lead to 
impaired wound healing due to the suppression of keratinocyte proliferation and migration in a transgenic mouse 
model14. Moreover, in addition to disrupting acute wound healing, mice over-expressing SOCS-3 also exhibit a 
prolonged inlammation phenotype that resembled characteristics of chronic wounds15. Taken together, these 
studies demonstrate the important regulatory role of SOCS-3 in the wound healing process. In contrast to SOCS-
3, SOCS-4 is a poorly investigated member of this family of proteins. Studies have indicated that SOCS-4 plays 
regulatory roles in inlammation caused by inluenza and parasite infection16, 17. An additional study has provided 
evidence to suggest that SOCS-4 may hold the potential to regulate hypoxia inducible factor (HIF)−1α, a medi-
ator involved in the adaptation to hypoxia18. Since inlammation and hypoxia are involved in wound healing, 
SOCS-4 may also have a regulatory role within the wound healing process.
Previous work within our laboratories has explored the expression of SOCS 1–7 in a cohort of chronic healing 
and non-healing wounds and demonstrated an upregulation of SOCS-3 and SOCS-4 transcript expression in 
non-healing chronic wounds, further suggesting the potential for these members to inluence the healing pro-
cess19. he current study explores the impact of SOCS-4 knockdown and SOCS-3 over-expression on keratinocyte 
and endothelial cell function to further characterise their potential to impact on traits associated with the healing 
process.
Results
Expression proile of SOCS-1 – SOCS-7 in HaCaT and HECV cell lines. he expression proile of 
SOCS-1 to SOCS-7 was explored in human HaCaT keratinocytes and HECV endothelial cell lines using RT-PCR 
(Fig. 1a). RT-PCR demonstrated that SOCS-2, SOCS-4, SOCS-5 and SOCS-6 were expressed in both HaCaT and 
HECV cell lines. Furthermore, the transcript levels of these four SOCS family members exhibited higher expres-
sion in HECV cells to that in HaCaT cells, though expression of SOCS-6 was weak in comparison to SOCS-2, -4 
and -5. No detectable expression of SOCS-1, SOCS-3 and SOCS-7 were observed in either HaCaT or HECV cells.
Generation of HaCaT and HECV SOCS-4 knockdown and SOCS-3 over-expression models. To 
further explore the signiicance of SOCS-3 and SOCS-4, over-expression or knockdown models were estab-
lished in HaCaT keratinocytes and HECV endothelial cells through transfection with either SOCS-3 coding 
sequences or ribozyme transgenes speciically targeted to SOCS-4. Following transfection and selection of the 
cell lines, SOCS-3 over-expression or SOCS-4 knockdown was assessed at the transcript and protein level using 
q-PCR and western blotting respectively. Transfection of both HaCaT and HECV cells with the SOCS-4 ribo-
zyme transgene signiicantly reduced transcript expression of SOCS-4 in comparison to the HaCaT or HECV 
pEF6 plasmid controls (Fig. 1b,c; p < 0.05 or p < 0.001, respectively). Similarly, SOCS-4 protein knockdown was 
observed in both cell lines in comparison to the pEF6 plasmid controls with a 48% and 22% decrease in SOCS-4 
expression observed in HaCaT and HECV cells respectively following transfection with the SOCS-4 ribozyme 
transgene (Fig. 1d,e). Transfection of HaCaT and HECV cells with the SOCS-3 over-expression plasmid also 
signiicantly enhanced transcript levels of SOCS-3 in comparison to controls transfected with the pEF6 plasmid 
alone (Fig. 1f,g; p < 0.001 or p < 0.0001, respectively) and resulted in an obvious increase in SOCS-3 protein 
expression, demonstrating 40% and 48% increases in protein levels compared to HaCaT and HECV pEF6 con-
trols respectively (Fig. 1h,i).
Impact of SOCS-3 over-expression and SOCS-4 knockdown on cell proliferation and attach-
ment. Knockdown of SOCS-4 did not impact on the 5 day proliferative rates of HaCaT (Fig. 2a) or HECV 
(Fig. 2b) cells and no signiicant diferences were seen between SOCS-4 knockdown cells and their respective 
pEF6 plasmid control cell lines (p > 0.05). Similarly, no diferences in 3 day growth rates were seen between 
SOCS-4 knockdown and the respective pEF6 control in either HaCaT or HECV cell lines (p > 0.05, data not 
shown). he impact on cell attachment and adhesion following SOCS-4 knockdown was assessed in both cell 
lines using an ECIS based attachment model (Fig. 2c,d) and a Matrigel adhesion model (Fig. 2e,f). Conlicting 
results were observed between the assays. ECIS analysis indicated that SOCS-4 knockdown reduced HaCaT cell 
attachment, as detected by change in resistance, in comparison to pEF6 control HaCaT cells at each time point 
(Fig. 2c; 1 hour, 2 hour, 3 hour, p < 0.01; 4 hour p < 0.0001) whereas the opposite was seen in the HECV model 
where SOCS-4 knockdown enhanced cell attachment at each tested time point in comparison to HECV pEF6 
control cells (Fig. 2d; p < 0.0001 at each time point). Utilising a diferent model, exploring cell attachment to 
a Matrigel artiicial basement membrane, no signiicant diferences in attachment were seen between HaCaT 
SOCS-4 knockdown and the pEF6 control line (Fig. 2e; p > 0.05) though a signiicant decrease in Matrigel 
attachment was seen following SOCS-4 knockdown in HECV cells compared to the HECV pEF6 control (Fig. 2f; 
p < 0.01).
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Over-expression of SOCS-3 decreased the 5 day proliferative rate of HaCaT cells in comparison to the pEF6 
plasmid control cells (Fig. 3a; p < 0.05) but did not signiicantly afect HECV cells (Fig. 3b; p > 0.05). No signii-
cant alterations were seen between SOCS-3 over-expression and respective pEF6 controls over a 3 day incubation 
period in either the HaCaT or HECV cell models (p > 0.05; data not shown). Using the ECIS based attachment 
model, an opposite trend to SOCS-4 knockdown was seen when SOCS-3 was over-expressed in HaCaT cells. 
SOCS-3 over-expression brought about an enhanced rate of cell attachment in comparison to HaCaT pEF6 con-
trol cells (Fig. 3c; 1 hour, 2 hour p < 0.01; 3 hour p < 0.001, 4 hour p < 0.0001). No signiicant efects on ECIS 
based attachment were seen between HECV SOCS-3 over-expression cells and HECV pEF6 control cells at all 
time points (Fig. 3d; p > 0.05 at each time point). In relation to attachment to Matrigel, SOCS-3 over-expression 
did not impact on HaCaT cell Matrigel attachment, with no signiicant diferences observed between HaCaT 
SOCS-3 over-expression and HaCaT pEF6 cells (Fig. 3e; p > 0.05), but did signiicantly enhance HECV attach-
ment in comparison to HECV pEF6 controls (Fig. 3f; p < 0.05).
Impact of SOCS-3 over-expression and SOCS-4 knockdown on cellular migration and angio-
genic potential. SOCS-4 knockdown was seen to signiicantly decrease the migratory rate of HaCaT cells, 
in comparison to HaCaT pEF6 control cells, in an ECIS based migration assay (Fig. 4a). Signiicant diferences 
were seen between HaCaT SOCS-4 knockdown and HaCaT pEF6 controls at all time points compared (1 hour 
p < 0.001, 2 hour, 3 hour, 4 hour p < 0.0001). However, SOCS-4 knockdown in the HECV cell line was seen to 
Figure 1. Expression proile and generation of SOCS-3 over-expression and SOCS-4 knockdown models. (a) 
RT-PCR screening of HaCaT and HECV cell lines for SOCS-1 (108 bp), SOCS-2 (461 bp), SOCS-3 (521 bp) 
SOCS-4 (541 bp), SOCS-5 (117 bp), SOCS-6 (131 bp), SOCS-7 (590 bp) and GAPDH (475 bp), negative control 
(-ve) represents ampliication of molecular biology grade water instead of cDNA. Veriication of SOCS-4 
transcript knockdown was assessed and conirmed using q-PCR in (b) HaCaT and (c) HECV cell lines. Protein 
knockdown in (d) HaCaT and (e) HECV cells were veriied using western blot analysis. Veriication of SOCS-3 
over-expression at transcript level was conirmed using q-PCR in (f) HaCaT and (g) HECV cell lines. Protein 
knockdown was veriied in (h) HaCaT and (i) HECV cells using western blot analysis. RT-PCR and western 
blot data represents cropped images, full length gels and blots are included in supplementary information. 
Representative data of a minimum of three independent repeats shown, error bars represent standard deviation, 
* represents p < 0.05, *** represents p < 0.001, **** represents p < 0.0001.
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have the opposite efect using this model and at all time points a signiicantly greater rate of migration, assessed by 
changes in resistance following wounding, were observed (Fig. 4b; p < 0.0001 at each time point). An EVOS based 
conventional scratch wounding assay was also used to assess migration rates of control and knockdown cells over 
a greater period of time. SOCS-4 knockdown in HaCaT cells was again found to signiicantly decrease cell migra-
tion in comparison to HaCaT pEF6 control, though at much later time points than those seen in the ECIS assays 
(Fig. 4c). Signiicant reductions in the migration rate of HaCaT SOCS-4 knockdown cells compared to HaCaT 
pEF6 cells was observed following 8 hours incubation and continued to the end of the experiment (8 hours, 
9 hours, 10 hours p < 0.05, 11 hours, 12 hours, 13 hours p < 0.01). In contrast with the ECIS results, assessment 
of cell migration in the HECV cell line using this model similarly demonstrated a decreased rate of migration 
was associated with SOCS-4 knockdown, compared to HECV pEF6 controls and this was again observed in the 
later stages of the experiment (Fig. 4d), with signiicant deviations observed from 13 hours onwards (all points 
p < 0.05). Knockdown of SOCS-4 was also observed to impede the tubule formation capacity of HECV cells 
Figure 2. Impact of SOCS-4 knockdown on cell proliferation and attachment. Five day proliferation rates of 
(a) HaCaT and (b) HECV cells following SOCS-4 knockdown, percentage respective pEF6 control of at least 
three independent repeats are shown, error bars represent the standard error of the mean. Cell attachment 
was assessed using an ECIS based method over 4 hours post seeding in (c) HaCaT and (d) HECV. Data, 
representative of at least three independent repeats shows mean change in resistance as detected by the ECIS 
system and was used to indicate cell attachment to the electrode, error bars represent standard deviation. 
A Matrigel matrix adhesion assay was also implemented to examine Matrigel attachment of (e) HaCaT and 
(f) HECV cells following SOCS-4 knockdown, mean percentage respective pEF6 control of at least three 
independent repeats are shown and error bars represent the standard error of the mean. ** represents p < 0.01, 
*** represents p < 0.001 and **** represents p < 0.0001.
www.nature.com/scientificreports/
5SCIENTIFIC REPORTS | ͽ:  6715 | DOI:ͷͶ.ͷͶ͹;/sͺͷͻͿ;-Ͷͷͽ-Ͷͼ;;ͼ-ͼ
seeded onto Matrigel and quantiication of total tubule perimeter per ield demonstrated a signiicant decrease in 
tubule formation compared to the HECV pEF6 control (Fig. 4e; p < 0.01).
ECIS based migration assays demonstrated an enhanced rate of migration following SOCS-3 over-expression 
in both HaCaT (Fig. 5a; 1, 2 hour p < 0.0001, 3, 4 hour p < 0.001 vs HaCaT pEF6) and HECV cells (Fig. 5b; 1 
hour p < 0.001, 2, 3, 4 hour p < 0.01 vs HECV pEF6). In contrast to this, EVOS based scratch wound analysis 
demonstrated no signiicant diferences between pEF6 control and SOCS-3 over-expression lines in both HaCaT 
(Fig. 5c) and HECV (Fig. 5d) cells. However, SOCS-3 over-expression was found to signiicantly enhance tubule 
perimeter in comparison to HECV pEF6 control cells (Fig. 5e; p < 0.01) indicating that SOCS-3 over-expression 
enhances the angiogenic potential of HECV cells.
Figure 3. Impact of SOCS-3 over-expression on cell proliferation and attachment. Five day proliferation rates 
of (a) HaCaT and (b) HECV cells following SOCS-3 over-expression, percentage respective pEF6 control of 
at least three independent repeats are shown and error bars represent the standard error of the mean. Cell 
attachment was assessed using an ECIS based method over 4 hours post seeding in (c) HaCaT and (d) HECV. 
Data, representative of at least three independent repeats shown, mean change in resistance, detected by the 
ECIS system, was used to indicate cell attachment to the electrode and error bars represent standard deviation. 
A Matrigel matrix adhesion assay was also implemented to examine Matrigel attachment of (e) HaCaT and 
(f) HECV cells following SOCS-3 over-expression, mean percentage respective pEF6 controls of at least three 
independent repeats are shown and error bars represent the standard error of the mean. * represents p < 0.05, 
** represents p < 0.01, *** represents p < 0.001 and **** represents p < 0.0001.
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Figure 4. Impact of SOCS-4 knockdown on cellular migration and tubule formation. Cellular migration was 
assessed using an ECIS model in (a) HaCaT and (b) HECV cells following SOCS-4 knockdown. Mean change 
in resistance following monolayer wounding was detected by the ECIS system and was used to quantify cell 
migration. Cellular migration was also explored using a conventional scratch wound assay, monitored by the 
EVOS system, in (c) HaCaT and (d) HECV cells following SOCS-4 knockdown. Angiogenic potential was 
assessed, following SOCS-4 knockdown in HECV cells using a Matrigel tubule formation assay (e). Data shown 
is representative of a minimum of three repeats, error bars represent standard deviation (a/b/e) and standard 
error of the mean (c/d), * represents p < 0.05, ** represents p < 0.01, *** represents p < 0.001 and **** 
represents p < 0.0001.
Figure 5. Impact of SOCS-3 over-expression on cellular migration and tubule formation. Cellular migration 
was assessed using an ECIS model in (a) HaCaT and (b) HECV cells following SOCS-3 over-expression. Mean 
change in resistance following monolayer wounding was detected by the ECIS system and was used to quantify 
cell migration. Cellular migration was also explored using a conventional scratch wound assay, monitored by 
the EVOS system, in (c) HaCaT and (d) HECV cells following SOCS-3 over-expression. Angiogenic potential 
was assessed following SOCS-3 over-expression in HECV cells using a Matrigel tubule formation assay (e). 
Data shown is representative of a minimum of three repeats, error bars represent standard deviation (a/b/e) 
and standard error of the mean (c/d), ** represents p < 0.01, *** represents p < 0.001 and **** represents 
p < 0.0001.
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Impact of SOCS-4 suppression on the responsiveness of HaCaT keratinocytes and HECV 
endothelial cells to epidermal growth factor and transforming growth factor beta. In order to 
gain insight into the signiicance of SOCS-4 in a more representative wound environment, cellular proliferation 
and migration assays were repeated, in the presence of 20 ng/ml epidermal growth factor (EGF) or 2 ng/ml trans-
forming growth factor beta (TGFβ), for both HaCaT keratinocytes (Fig. 6) and HECV endothelial cells (Fig. 7). 
Treatment of HaCaT pEF6 control cells and SOCS-4 knockdown cells with EGF appeared to reduce prolifera-
tion rates in comparison to the respective untreated control and this trend was seen to be signiicant following 
HaCaT pEF6 treatment with EGF at the early 3 day time point (p < 0.05 vs untreated HaCaT pEF6), though this 
level of signiicance was not reached at the later 5 day time point. he addition of TGFβ appeared to bring about 
a slight enhancement in proliferation in both HaCaT pEF6 and HaCaT SOCS-4 knockdown cells, though this 
efect was not found to be signiicant (Fig. 6a,b). Scratch wounding assays (Fig. 6c,d), performed in the presence 
of each of the growth factors, indicated a small, non-signiicant decrease in migration in both pEF6 and SOCS-4 
knockdown HaCaT cells following treatment with TGFβ. Interestingly, whilst treatment with EGF did very little 
to inluence the migrational rates of pEF6 control HaCaT cells, a clear enhancement was seen following EGF 
treatment of SOCS-4 knockdown cells, though this did not reach signiicance. Similar trends were seen within the 
HECV endothelial cell models. Proliferation of both pEF6 and SOCS-4 knockdown cells was generally unafected 
by either treatment at the 3 day time point, though, as with HaCaT cells, a slight, non-signiicantly decreased 
proliferative rate was seen following EGF treatment at the 5 day incubation point. Interestingly, TGFβ treatment 
again enhanced 5 day proliferative rates in both pEF6 and SOCS-4 knockdown cells, though a greater efect of 
TGFβ was seen following SOCS-4 knockdown (p < 0.05 vs. untreated HECV SOCS-4 knockdown cells) than in 
the pEF6 control cell line (Fig. 7a,b). TGFβ appeared to slightly reduce HECV pEF6 migration at the later time 
point, though this was not found to be statistically signiicant, and had very little impact on the migration rates 
of SOCS-4 knockdown HECV cells. In keeping with the observed efects of EGF on HaCaT cell migration, treat-
ment of HECV cells with EGF had a diferential efect on the migration of pEF6 control and SOCS-4 knockdown 
cells. Treatment with EGF did not obviously impact on HECV pEF6 cell migration but brought about a signiicant 
increase in HECV SOCS-4 knockdown cells at the later 6 hour and 8 hour time points (both p < 0.05 vs. untreated 
HECV SOCS-4 knockdown cells) (Fig. 7c,d).
SOCS-4 suppression alters phospho protein expression within HaCaT keratinocytes. In 
order to explore the implications of targeting SOCS-4 in keratinocytes, a protein microarray was undertaken 
to explore diferences in phospho protein expression patterns in control and SOCS-4 knockdown HaCaT cells. 
Samples were sent to and processed by Kinexus Bioinformatics (Vancouver, Canada) using a KAM-880 array 
chip. Analysis of this chip demonstrated a number of differences between the control and SOCS-4 knock-
down samples and included a diverse range of phosphorylation events, potentially implicating a regulatory 
role for SOCS-4 in a wide variety of signalling pathways. Diferential expression of phospho protein expression 
Figure 6. Impact of SOCS-4 suppression on the proliferative and migratory responses of HaCaT keratinocytes 
to EGF and TGFβ. Proliferative rates of (a) HaCaT pEF6 and (b) HaCaT SOCS-4 knockdown cells in addition 
to 20 ng/ml EGF or 2 ng/ml TGFβ were assessed using a MTT growth assay over 3 and 5 days. Cellular 
migration in response to 20 ng/ml EGF and 2 ng/ml TGFβ was also explored using a conventional scratch 
wound assay on (c) HaCaT pEF6 and (d) HaCaT SOCS-4 knockdown cells. Data shown are mean values of a 
minimum of three independent repeats, error bars represent the standard error of the mean and * represents 
p < 0.05.
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between the control and SOCS-4 knockdown HaCaT cells was assessed through Z-ratio analysis and scaling. 
Our results indicated that following suppression of SOCS-4 in HaCaT cells the ten most signiicantly enhanced 
phosphorylation events were Met Y1003, platelet derived growth factor receptor alpha (PDGFRα) Y754, SH2 
domain-containing transforming protein 1 (ShC1) Y239/Y240, double-stranded RNA-dependent protein-serine 
kinase (PKR1) T446, cyclin-dependent kinase 1/2 (CDK1/2) Y15, NFKB inhibitor epsilon (IkBe) S22, histone 
deacetylase 5 (HDAC5) S498, Forkhead box protein O1 (FKHR) S256, c- Jun N-terminal kinase 1/2/3 (JNK 
1/2/3) T183/Y185 and cyclin-dependent protein-serine kinase 4 (CDK4) T172 (Fig. 8a). Subsequently, the ten 
most signiicantly de-phosphorylated events following SOCS-4 suppression in HaCaT cells were, ribosomal S6 
protein-serine kinase 1/2/3 (RSK 1/2/3) T573, ribosomal protein S6 kinase beta-1 (S6K) T412, vascular endothe-
lial growth factor receptor-tyrosine kinase 2 (VEGFR2) Y1214, signal transduction protein CBL (c-Cbl) Y700, Src 
proto-oncogene-encoded protein-tyrosine kinase (Src) Y418, EGFR Y1110, retinoblastoma-associated protein 1 
(Rb) T821, focal adhesion kinase (FAK) Y397, insulin receptor substrate 1 (IRS1) (S639) and Rb S608 (Fig. 8b).
Discussion
During the proliferation and re-epithelialisation phase, the proliferative behaviour and the migratory action of 
epithelial cells partially determine wound healing speed, thus, the epithelial cell is an essential cell type involved 
in the wound healing process. Many studies have indicated that SOCS proteins have regulatory roles in epi-
thelial function with some studies, particularly focusing on SOCS-3, indicating a potential association between 
SOCS and wound healing components13–15, 20. Hence, SOCS family members show promise through their capac-
ity to inluence epithelial function and cytokine signalling, as regulators of the wound healing process. Previous 
work within our laboratory has demonstrated an elevated transcript expression of both SOCS-3 and SOCS-4 in 
non-healing chronic wounds compared to healing chronic wounds19. In the human HaCaT keratinocyte and 
HECV endothelial cell models used in this study, a diferential expression pattern of SOCS-1 to -7 was seen. Clear 
expression of SOCS-2, -4 and -5 were demonstrated whilst weak SOCS-6 expression was also noted. However, no 
transcript expression was observed for SOCS-1, -3 and -7. Taken together with our previous clinical observations, 
the current study aimed to further explore the importance of SOCS-3 and SOCS-4 in wound healing, character-
ising the efect of inducing SOCS-3 or suppressing SOCS-4 expression to explore their role in keratinocyte and 
endothelial cell function and implications in wound healing.
SOCS-3 has been found to negatively regulate STAT-3 activation21 and given that STAT-3 has been shown to 
mediate epithelial cell apoptosis22, SOCS-3 may hold the potential to regulate epithelial cell growth. In addition, 
studies on keratinocytes and mouse models discovered a regulatory role of SOCS-3 in the proliferation and dif-
ferentiation of epithelial cells14 and observed a correlation between SOCS-3 and exacerbated inlammation15, 
emphasising the importance of SOCS-3 in the chronic wound environment. his is in line with the inding of 
further investigations on SOCS-3 deicient mouse models in which severe inlammation resulting from STAT-3 
hyper-activation was observed, and skin homeostasis indicated to be tightly regulated via the IL-6/STAT-3/
Figure 7. Impact of SOCS-4 suppression on the proliferative and migratory responses of HECV endothelial 
cells to EGF and TGFβ. Proliferative rates of (a) HECV pEF6 and (b) HECV SOCS-4 knockdown cells in 
addition to 20 ng/ml EGF or 2 ng/ml TGFβ were assessed using a MTT growth assay over 3 and 5 days. Cellular 
migration in response to 20 ng/ml EGF and 2 ng/ml TGFβ was also explored using a conventional scratch 
wound assay on (c) HECV pEF6 and (d) HECV SOCS-4 knockdown cells. Data shown are mean values of a 
minimum of three independent repeats, error bars represent the standard error of the mean and * represents 
p < 0.05.
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SOCS-3 axis13. Another study showed that positive SOCS-3 expression was found in the epithelial and endothe-
lial cells adjacent to inlammatory tissue, though in normal human tissues SOCS-3 is predominantly expressed 
in endothelial cells23. Hence, SOCS-3 may have distinct roles in epithelial and endothelial cells during the inlam-
mation stage. Further studies using SOCS-3 deicient mouse models have suggested a potential role for SOCS-3 
in leukocyte iniltration24, further highlighting its signiicance during inlammation. In our current study we gen-
erated a human HaCaT keratinocyte and a HECV endothelial cell model over-expressing SOCS-3 and conirmed 
this over-expression at both the transcript and protein level. In vitro cell functional assays were conducted on the 
SOCS-3 over-expression HaCaT and HECV mutant lines. he upregulation of SOCS-3 did not signiicantly afect 
the proliferation rate of the endothelial cells over a 5-day incubation period, whereas, a signiicant decrease in 
proliferation was seen in SOCS-3 over-expression HaCaT cells compared to the respective control line. his is 
in agreement with a previous study on a SOCS-3 stable over-expression HaCaT cell model using a diferent type 
of vector20, though this inhibition was seen much sooner, following 24 hours opposed to 5 days. his may be due 
to difering SOCS-3 over-expression eiciencies between the studies. Moreover, transgenic mice over-expressing 
SOCS-3 in keratinocytes, demonstrated impaired wound closure rates, atrophied wound edge margin epithelia 
and a reduction in proliferating cells14, further strengthening the role of SOCS-3 in suppressing keratinocyte 
proliferation. Taken together these studies imply an inhibitory role for SOCS-3 in keratinocyte proliferation. 
Cell attachment following HaCaT and HECV SOCS-3 over-expression was also explored using diferent meth-
odologies. A signiicantly elevated adherent ability was observed in the SOCS-3 over-expression HaCaT line at 
the irst hour ater cell seeding, and remained consistent until the fourth hour in the ECIS based initial adhesion 
assay, whereas, no statistical diference was seen in the Matrigel adhesion assay. However, regarding HECV, the 
upregulation of SOCS-3 increased the adhesive ability of this cell line in the Matrigel adhesion assay, whereas, 
no signiicant efect of SOCS-3 over-expression on HECV adhesion was found in the ECIS based initial adhe-
sion assay. Such discrepancy between the two methodologies may suggest that SOCS-3 afects keratinocyte and 
endothelial cell adhesion to diferent surface matrix via diferent mechanisms within each cell type or be due to 
diferences between the measurement of resistance change and more conventional methods to quantify adhesion 
in the Matrigel based assays. However, since the structure and texture of the Matrigel matrix resembles the extra-
cellular matrix (ECM) environment in many tissues and has been extensively recognised, the observations from 
the Matrigel adhesion assay may indicate a more accurate physiological trend. Similarly, diferential results were 
seen between EVOS based and ECIS based migration assays. SOCS-3 over-expression did not afect keratinocyte 
Figure 8. Impact of SOCS-4 suppression on HaCaT phosphorylation status. Summary of Kinexus protein 
microarray analysis highlighting the ten most highly upregulated (a) and down regulated (b) phospho proteins 
within HaCaT keratinocytes following SOCS-4 knockdown.[Met, met proto-oncogene; PDGFRa, platelet 
derived growth factor receptor alpha; shc1, SH2 domain-containing transforming protein 1; PKR1, Double-
stranded RNA-dependent protein-serine kinase; CDK1/2, cyclin-dependent kinase 1/2; IkBe, NFKB inhibitor 
epsilon; HDAC5, Histone deacetylase 5; FKHR. Forkhead box protein O1; JNK1/2/3, c- Jun N-terminal kinase 
1/2/3; CDK4, Cyclin-dependent protein-serine kinase 4; RSK1/2/3, Ribosomal S6 protein-serine kinase 1/2/3; 
S6K, Ribosomal protein S6 kinase beta-1; VEGFR2, Vascular endothelial growth factor receptor-tyrosine kinase 
2; c-Cbl, Signal transduction protein CBL; Src, Src proto-oncogene-encoded protein-tyrosine kinase; EGFR, 
Epidermal growth factor receptor-tyrosine kinase; FAK, Focal adhesion kinase; IRS1, Insulin receptor substrate 
1; Rb, Retinoblastoma-associated protein 1].
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or endothelial cell migration in the EVOS based migration assay, whereas signiicantly elevated migration onto 
the gold electrode was observed in the ECIS based migration assay. his may again be due to the diferent cell 
substratum that the cells migrate across or diferent sensitivities in the quantiication of the migration, whether 
this be physical distance between two wound fronts or changes in resistance resulting from cells moving onto an 
electrode. A previous in vivo study on a keratinocyte-speciic SOCS-3 over-expressing mouse model discovered 
a severely impaired wound healing phenotype accompanied by an augmented inlammatory response, alteration 
of the inlammatory chemokine proile and a prolonged presence of neutrophils and macrophages, indicating 
the detrimental efect of the SOCS-3 on wound healing15. Interestingly, no signiicant change, in terms of migra-
tory rate, was seen in either keratinocyte or endothelial cells following SOCS-3 over-expression from the EVOS 
migration assay, which seems to be contradictory to the previously reported in vivo study. However, the systems 
tested here are simple in vitro assays which may not fully take into account the more complex microenvironment 
and subsequent cross-talk between cells and a variety of cytokines, growth factors and other contributing factors 
present in the complex in vivo systems. Additionally, since there is little evidence demonstrating the direct in vitro 
efect of SOCS-3 on keratinocyte migration, it is possible that SOCS-3 may be a more signiicant factor in the 
context of extra-cellular stimuli. For example Tokumaru et al. previously highlighted the importance of SOCS-3 
in the phosphorylation of STAT-3 and in hepatocyte growth factor (HGF) induced migration within keratino-
cytes25. SOCS-3 over-expression in HECV endothelial cells resulted in enhanced tubule formation on Matrigel, 
suggesting a pro-angiogenic inluence. Many studies have demonstrated that SOCS-3 plays an inhibitory role in 
angiogenesis in a variety of pathologies, especially cancer26. Interestingly, SOCS-3 has been discovered to be a 
suppressor of pathological angiogenesis but not a regulator of physiological vascularisation in an investigation on 
a SOCS-3 deicient mouse model27. hus, it may be that the inluence of SOCS-3 on angiogenesis may depend on 
the particular microenvironmental conditions or particular cell type tested. Hence it is of importance to further 
explore the angiogenic inluence of SOCS-3 in other endothelial cell lines.
Unlike SOCS-3, SOCS-4 is the least investigated molecule within the SOCS family, and there are currently no 
studies reporting the potential link between SOCS-4 and wound healing. SOCS-4 has been found to be induced 
by EGF stimulation28, and in turn inhibits EGFR-dependent signalling via competing for the docking site with 
STAT-3 to the phospho-residue on EGFR and through the elevation of EGFR degradation29. In addition, the 
downregulation of SOCS-4 correlates with the elevation of STAT-3 and STAT-617, indicating multiple potential 
targets of SOCS-4 on the STAT family members. Investigations using a SOCS-4 deicient mouse model and a 
SOCS-4 knockdown cell model demonstrated the important regulatory role of SOCS-4 in the inlammatory 
response to inluenza and parasite infection, as well as a novel function of SOCS-4 in modulating T cell recep-
tor (TCR) signalling16, 17. Moreover, another study hypothesised that SOCS-4 may have a regulatory efect on 
HIF-1α18. Since EGF, STAT-3, STAT-6 and HIF-1α, as well as inlammation, are components involved in the 
wound healing process, it is feasible that SOCS-4 may also play an important role in regulating wound healing, 
and this is further highlighted by our previous clinical observations indicating the dysregulation of this molecule 
between non-healing and healing chronic wounds19. To further explore the importance of SOCS-4 we targeted 
SOCS-4 expression in both human HaCaT keratinocytes and HECV endothelial cells using ribozyme transgenes, 
conirming successful knockdown at both transcript and protein levels. Characterisation of these mutant lines 
demonstrated that SOCS-4 did not have any efect on the proliferative rate of these cell types, at least within 5 
days. Additionally, HaCaT migration was signiicantly impaired following SOCS-4 downregulation, and such a 
trend was consistent in both the ECIS and EVOS migration assays conducted, although the signiicant diference 
between the SOCS-4 knockdown and the control line was delayed 8 hours in the EVOS assay in comparison 
to the ECIS assay. his again may represent diferences in the sensitivities of the two methodologies and their 
quantiication of cell migration. Interestingly, the investigation on the migration of SOCS-4 mutant endothelial 
cells demonstrated contradictory results between the two methodologies, demonstrating a pro-migratory efect 
in the ECIS based system and an inhibitory efect, similar to that seen in HaCaT cells, in the EVOS based sys-
tem. his may potentially be due to the diferent substratum and how SOCS-4 regulates migration across such 
matrix within the HECV cell line and will require further clariication utilising additional methodologies. he 
data does however provide novel evidence that SOCS-4 plays an active role in the regulation of migration in 
these two cell types. A study on a thyroid cancer cell line has suggested that SOCS-4 has an inhibitory efect on 
migration and that inhibition of SOCS-4 by miR-25 could promote thyroid cancer cell migration30. In the current 
study, particularly in terms of HaCaT keratinocytes, suppression of SOCS−4 inhibited migration, indicating a 
pro-migratory role for SOCS-4 in this cell line. his may highlight a diverse regulatory role for SOCS-4 in difer-
ent cellular microenvironments through variant signalling pathways or potentially cell speciic functions. Similar 
to the results obtained for the SOCS-3 over-expression models, contrasting results were seen between the ECIS 
based and Matrigel adhesion assays. he initial adhesive ability of HaCaT was signiicantly decreased following 
the downregulation of SOCS-4 at the irst hour following cell seeding and this trend was consistent until the 
fourth hour in the ECIS based initial adhesion assay, whereas, such cell behaviour was not afected by SOCS-4 
knockdown in the Matrigel cell adhesion assay. Moreover, in terms of the HECV cell line, the ECIS based initial 
adhesion assay displayed a signiicantly elevated initial adhesive ability of the SOCS-4 knockdown line ater cell 
seeding until the fourth hour, whereas, a contrasting result was observed in the Matrigel cell adhesion assay. As 
previously discussed, this may relate to difering sensitivities or the diferential substratum present in the difer-
ing methodologies. Hence our current data may suggest a substratum speciic role for SOCS-3 and SOCS-4 and 
it may be that this relates to some undiscovered role of SOCS-3 and SOCS-4 to regulate cell-matrix adhesion 
molecules, such as integrins. However, further, intense scientiic investigation is required to further explore this 
theory and fully eluicidate the role of SOCS-3 and SOCS-4 in matrix adhesion. Nevertheless, the data presented, 
particularly in terms of the HECV endothelial model, strongly suggests that SOCS-4 plays an active role in reg-
ulating cell-substrate attachment. We also investigated the impact of SOCS-4 suppression on tubule formation 
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and angiogenic capacity, demonstrating a signiicant reduction in tubule formation on Matrigel following HECV 
SOCS-4 knockdown.
To further explore the signiicance of SOCS-4 in the wound environment and its links to EGFR signalling, 
we conducted proliferation and migration assays on HaCaT and HECV control and SOCS-4 suppressed cells in 
the presence of EGF or TGFβ, both cytokines established to be key players in wound healing and dysregulated in 
chronic wound environments8, 31. Previous data has suggested some links between EGF signalling and SOCS-428, 29. 
In the current study we demonstrated that keratinocytes and endothelial cells with suppressed levels of SOCS-4 
appear to have a greater pro-migratory response to EGF and SOCS-4 suppressed endothelial cells have a greater 
proliferative response to TGFβ. Hence, SOCS-4 appears to be a key player in regulating cellular traits associated 
with wound healing in response to EGF and TGFβ and may thus be a factor inluencing wound response to such 
growth factors or clinical therapies involving these factors. In keeping with this theory, a wide variety of phospho 
protein expression changes were also observed, using a protein microarray system, in response to HaCaT SOCS-4 
knockdown. he highlighted top 10 up- and down- regulated proteins demonstrate the capacity of SOCS-4 to 
inluence a wide variety of signalling pathways and whilst intense future work will be required to validate and 
fully elucidate speciic mechanisms, these initial observations highlight a number of interesting mechanisms to 
potentially explain the functional characteristics observed here and further link SOCS-4 to wound healing. Of 
particular interest was the observation that SOCS-4 suppression decreased Y1110 phosphorylation of EGFR. 
EGFR signalling has been indicated as an integral pathway involved in wound healing and in keratinocyte func-
tion31. Similarly, EGFR expression has been previously shown to be reduced in chronic wounds and keratino-
cytes at the non-healing wound edge were found to be unresponsive to EGF32. Phosphorylation of EGFR Y1110 
(Y1086) has been proposed to lead to recruitment of additional molecules and progression of downstream sig-
nalling33, 34. his seems in contrast with our in vitro data, demonstrating an enhanced migratory response to 
EGF. When taken together with the literature it is likely that SOCS-4 plays a complex regulatory role, involving 
feedback loops, in EGF signalling and how keratinocytes and endothelial cells respond to this growth factor in 
the wound environment. Further work is required to establish fully the observation of the protein microarray and 
also to explore such a regulatory relationship in the presence of other factors, such as EGF itself, more represent-
ative of a true wound or chronic wound environment.
Other highlighted molecules of interest include the HGF tyrosine kinase receptor Met. HGF/Met signalling 
has been extensively studied and identiied as a key pathway in processes such as tissue repair and cancer progres-
sion35, 36. Previous work undertaken by our laboratories has explored HGF and Met expression, together with a 
range of activator and inhibitors, in normal skin and acute as well as chronic wound tissues. Immunohistochemal 
analysis of these tissues indicated a generally decreased protein expression of Met in chronic wounds compared 
to acute wounds and this trend was more obvious as you moved further from the wound edge, though q-PCR 
analysis did not suggest any change in gene expression between these tissue types37. he current study identi-
ies a potential mechanism where SOCS-4 suppression could enhance the phosphorylation of Y1003 in Met. 
his phosphorylation site has been shown to be a binding site for Cbl, resulting in ubiquitination and subse-
quent internalisation and degradation of the Met receptor, and mutations at this residue has been found to have 
oncogenic implications35, 36. Taken together with our current data, this could suggest a novel role for SOCS-4 
in regulating Met turnover within keratinocytes and hence their responsiveness to HGF. Additionally, knock-
down of SOCS-4 in HaCaT cells resulted in decreased phosphorylation of focal adhesion kinase (FAK) Y397. 
Auto phosphorylation of FAK at Y397 is a key event involved in the activation of FAK, occurring in response to 
numerous stimuli and implicated in a variety of downstream signalling events and functional changes such as 
enhanced migration38. FAK activation has previously been observed to promote keratinocyte migration during 
wound healing39. Additionally, SOCS-4 knockdown also reduced Src Y418 expression, a key activation residue. It 
has previously been shown that Src activation requires activation of FAK through Y397 phosphorylation and FAK 
is able to modulate cell migration through interaction of FAK/Src complex and p130Cas40, 41. Hence a decrease in 
both of these phosphorylation events could also account for the decreased rate of migration observed in SOCS-4 
knockdown HaCaT cells.
Taken together, the current data has highlighted the potential for SOCS-3 and SOCS-4 to inluence a number 
of cellular traits in HaCaT keratinocytes and HECV endothelial cell lines. Given the importance of these two cell 
types in the wound healing process the current study provides additional support for the importance of SOCS-3 
in wound healing and also novel data demonstrating a potential role for SOCS-4 in this process. Furthermore, our 
data suggests a role for SOCS-4 in regulating the response of keratinocytes and endothelial cells to factors present 
in the wound such as EGF and TGFβ. Further scientiic study, utilising additional cell lines, primary cultures and 
more complex multi-cellular environments, is needed to fully elucidate the signiicance of these SOCS members 
in wound healing and realise their clinical potential.
Methods
Cells and materials. Two cell lines were used for in vitro model generation and functional assay inves-
tigation in this study. he immmortalised keratinocyte cell line (HaCaT)42 was purchased from the German 
Cancer Research Centre (Heidelberg, Germany). he human HECV endothelial cell line was purchased from 
Interlab Cell Line Collection (Genova, Italy). Both HaCaT and HECV cell lines were routinely cultured in 
DMEM/Ham’s F12 with L-Glutamine medium (Sigma-Aldrich, Inc., Dorset, UK), supplemented with antibiotics 
(Sigma-Aldrich, Inc., Dorset, UK), 10% fetal calf serum (FCS) (Sigma-Aldrich, Inc., Dorset, UK) and incubated 
at 37.0 °C, 5% CO2 and 95% humidity. Recombinant human epidermal growth factor (EGF) and transforming 
growth factor beta (TGFβ) were purchased from Insight Biotechnology Ltd., (Middlesex, UK) and Biotechne 
(Abingdon, UK) respectively. EGF was used at a concentration of 20 ng/ml and TGFβ was used at a concentration 
of 2 ng/ml within the functional assays.
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Total RNA isolation and reverse trascription. RNA was isolated using TRI-reagent (Sigma-Aldrich, 
Inc., Dorset, UK) under the manufacturer’s instructions. Following isolation, the RNA pellet was resuspended, 
quantiied using a NanoPhotometerTM (IMPLEN; Genelow Ltd., Lichield, UK) and standardised before under-
taking reverse transcription using the GoScriptTM Reverse Transcription System kit (Promega Corporation, 
Madison, WI, USA) to generate cDNA.
Polymerase chain reaction (PCR) and agarose gel electrophoresis. Conventional PCR was carried 
out using GoTaq Green master mix (Promega, Madison, USA) to examine the expression proile of SOCS-1 to -7 
in HaCaT and HECV cell lines, and speciic primers were designed using Beacon designer sotware (PREMIER 
Biosoft International, Palo Alto CA, USA) (Table 1) and synthesised by Sigma-Aldrich, Inc. (Dorset, UK). 
Reactions were ampliied in a 2720 hermal Cycler (Applied Biosystems, Paisley, UK) before being separated 
on an agarose gel, stained with SYBRsafe (Life Technologies, Paisley, UK) and visualised using a Syngene gel doc 
system (U: Genius 3) under blue light.
Quantitative Polymerase Chain Reaction (q-PCR). q-PCR was used to verify transcript knockdown or 
over-expression. his methodology has been previously described and utilised in our laboratory43. In brief, prim-
ers were designed speciically to SOCS-3 and SOCS-4 (Table 1). To the reverse primer of each pair a Z sequence 
(ACTGAACCTGACCGTACA) was added in order to allow incorporation of the FAM tagged Uniprimer probe 
(Intergen Inc., New York, USA) and subsequent luorescent detection. An internal standard was run alongside 
the genes of interest and used to generate a standard curve, allowing relative transcript copy numbers to be 
determined. Sample reactions, including forward primer, reverse Z-sequence tagged primer, Uniprimer probe, 
cDNA, molecular biology grade water and PrecisionFAST 2X q-PCR Mastermix (PrimerDesign, Eastleigh, UK) 
were ampliied and detected using a StepOne plus (Life Technologies, Paisley, UK) q-PCR system. Target gene 
expression was further normalised based on the detection of the GAPDH housekeeping gene.
Generation of SOCS-4 knockdown and SOCS-3 over-expression models. Ribozyme transgenes 
were speciically designed based on the predicted secondary structure of human SOCS-4 generated using Zukers 
RNA Mfold programme44 and synthesised using touchdown PCR combined with REDTaq® Ready MixTM PCR 
Reaction Mix (Sigma-Aldrich, Dorset, UK). Ribozyme sequences used in the study are outlined in Table 1.
A high idelity enzyme mix kit (Fisher Scientiic UK, Loughborough, UK) and speciic primer pairs (Table 1) 
were used to amplify the coding sequence of human SOCS-3 from the MRC-5 normal lung ibroblast cell line. he 
ampliied PCR product was then separated by gel electrophoresis, and the gel was excised at the predicted size of 
SOCS-3 coding sequence before puriication using a GenEluteTM Gel Extraction Kit (Sigma-Aldrich, Dorset, UK) 
and Sanger sequencing of the extract (Source Bioscience, Nottingham, UK) was undertaken to verify identity.
Generated over-expression or ribozyme transgene sequences were subsequently cloned into the pEF6/V5-His 
TOPO® TA expression system (Life Technologies, Paisley, UK) to generate SOCS-3 over-expression or SOCS-4 
knockdown plasmids in accordance with the manufacturer’s guidelines. hese plasmids were used to transfect 
HaCaT and HECV wild type cells using electroporation. Following transfection cells underwent a selective period 
(media containing 5 µg/ml blasticidin) before being transferred to and cultured routinely in maintenance medium 
(media containing with 0.5 µg/ml blasticidin).
Cellular lysis and protein extraction. Upon reaching suicient conluency, cells were washed with ice 
cold sterile PBS and scraped from the lask using a sterile cell scraper in sterile PBS. he cell suspension was 
centrifuged at 2500 rpm for 10 minutes before lysing the pellet in lysis bufer and placing on a rotating wheel 
(Wolf laboratories, York, UK) at 4 °C for 45 minutes. Subsequently, the lysate was centrifuged for 15 minutes 
at 13,000 rpm and the supernatant retained and quantiied using a Bio-Rad DCTM protein assay kit (Bio-Rad, 
Target gene/Sequence Forward Reverse
SOCS-1 5′-GATGGTAGCACACAACCAG 5′-ACTGAACCTGACCGTACAGAGGAAGAGGAGGAAGGTT
SOCS-2 5′-GTCAGACAGGATGGTACTGG 5′-CTGGAATTTATATTCTTCCAA
SOCS-3 5′-AAGACCTTCAGCTCCAAGA 5′-GTCTTCCGACAGAGATGCT
SOCS-4 5′-CAGCTGTTCATCCATTGAG 5′-CCATTTGGGTTTGTTTCTT
SOCS-5 5′-AGTCAAAGCCTCTCTTTTCC 5′-ACTGAACCTGACCGTACACATTTTGGGCTAAATCTGA
SOCS-6 5′-CCTTACAGAGGAGCTGAAAA 5′-ACTGAACCTGACCGTACACGAAAAGAAAAGAACCATC
SOCS-7 5′-AGACTAACAGCTGCTCGGAA 5′-CCCACTGATATCATCTAGGAGGC
GAPDH 5′-GGCTGCTTTTAACTCTGGTA 5′-GACTGTGGTCATGAGTCCTT
SOCS-3 (q-PCR) 5′-TCAAGACCTTCAGCTCCA 5′-ACTGAACCTGACCGTACAGTCACTGCGCTCCAGTAG
SOCS4 (q-PCR) 5′-GGCAGTGTTTTCCAATAAAG 5′-ACTGAACCTGACCGTACAAGGTGGGAAAGGACACTTAT
GAPDH (q-PCR) 5′-CTGAGTACGTCGTGGAGTC 5′-ACTGAACCTGACCGTACACAGAGATGATGACCCTTTTG
SOCS-4 (ribozyme transgene)
5′-CTGCAGTTCACTGATATGAATT 
TTCCTTTTAGACGCTGATGAGTCCGTGAGGA
5′-ACTAGTCGGCACTCTTCAGGGCTTTTCGTCCTCACGGACT
SOCS-3 (coding sequence ampliication) 5′-ATGGTCACCCACAGCAAGTT 5′-TTAAAGCGGGGCATC
Table 1. Primers/sequences used in the study. Z Sequence represented by ‘ACTGAACCTGACCGTACA’.
www.nature.com/scientificreports/
13SCIENTIFIC REPORTS | ͽ:  6715 | DOI:ͷͶ.ͷͶ͹;/sͺͷͻͿ;-Ͷͷͽ-Ͷͼ;;ͼ-ͼ
Laboratories, Hemel-Hempstead, UK). he concentration of the protein samples were then standardised to 2 mg/
ml, diluted in 2x Lamelli sample bufer (Sigma-Aldrich, Dorset, UK) and boiled at 100 °C for 5 minutes before 
being stored at −20 °C for further use.
Tris-glycine sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting. Tris-glycine SDS-PAGE was undertaken using an OmniPAGE VS10DSYS vertical elec-
trophoresis system (OmniPAGE, Cleaver Scientiic Ltd., Rugby, UK) to separate proteins before wet transfer to a 
PVDF membrane (EMD Millipore Corporation, Billerica, MA, USA).
Once complete, the membrane was incubated in blocking solution (5% low fat milk and 0.1% Tween 20 in 
TBS) for at least 1 hour at room temperature. he membrane was then probed with primary antibody (SOCS-4, R 
& D systems, Abingdon, UK; SOCS-3, Abcam, Cambridge, UK; GAPDH, Insight Biotechnology Ltd., Middlesex, 
UK) at 4 °C overnight, subjected to washes and incubated with a horseradish peroxidase (HRP) conjugated sec-
ondary antibody (Anti-mouse or Anti-goat, Sigma-Aldrich, Dorset, UK) for 2 hours before washing and protein 
band detection using a EZ-ECL Chemiluminescent Detection Kit (Biological industries, Kibbutz Beit-Haemek, 
Israel) and visualisation in a G:BOX Chemi XRQ imaging system (Syngene, Cambridge, UK).
Electric cell-substrate impedance sensing (ECIS) based initial adhesion and migration 
assay. Electric cell-substrate impedance sensing (ECIS) instruments (Applied Biophysics Inc., NJ, USA) 
were applied to investigate cellular behaviour based on the impedance parameter detected from gold electrodes 
coated on the bottom of a 96-well array (Applied Biophysics Inc., NJ, USA). his method has been previously 
described43. In brief, prior to cell seeding, ECIS arrays containing growth medium were stabilised using the sta-
bilisation function within the system and washed. Cells were seeded at an appropriate density before the 96-well 
array was equipped in the incubated array station and changes in resistance/impedance measured over the course 
of the experiment. he irst four hours of data was analysed for initial attachment and spreading. Once the resist-
ance curve reached plateau electrical wounding was applied for 20 seconds at 3000µA and 60,000 Hz, to generate a 
wound in the monolayer before recording the change in resistance following recovery of the monolayer to analyse 
cellular migration over a four hour period.
In vitro thiazolyl blue tetrazolium bromide (MTT) cell proliferation assay. Cell growth was 
assessed using a MTT cell proliferation assay. Cells were trypsinised, counted and seeded at a density of 2,000 
cells/well. Plates were prepared in triplicate and incubated for 24 (1 day), 72 (3 days) and 120 hours (5 days) at 
37.0 °C, 5% CO2 and 95% humidity. Following appropriate incubation a working concentration of 0.5 mg/ml 
MTT was added and the plates were incubated for a further 4 hours. Subsequently, the medium was aspirated and 
200 µl of dimethyl sulphoxide (DMSO) was added and incubated for 10 minutes. he solution was gently mixed 
before reading the absorbance of each well at 540 nm using an ELx800 plate reading spectrophotometer (Bio-Tek, 
Wolf laboratories, York, UK). he cell number in each well was determined through the absorbance and a per-
centage increase at each time point was calculated in reference to the day 1 plate.
In vitro cell adhesion assay. Cell adhesion assays were used to examine cellular adhesion to Matrigel 
matrix (Corning Incorporated, Flintshire, UK). Five micrograms of Matrigel was pre-dried into the wells of a 
96 well plate before rehydration and cell seeding at a density of 40,000 cells/well. Following seeding, the plates 
were incubated for 45 minutes before aspirating the medium and washing with PBS. Two difering methods 
were subsequently applied to quantify adhesive cells. In the case of SOCS-4 knockdown models, cells were ixed 
in 4% formalin for a minimum of 10 minutes before washing in water and staining using 0.5% crystal violet 
(Sigma-Aldrich, Dorset, UK). his was subsequently rinsed of the plate which was allowed to dry before captur-
ing images and quantifying adherent cell numbers. In the case of SOCS-3 over-expression cells, following washing 
the plate was incubated with 0.5 mg/ml MTT for 4 hours. Subsequently, the solution was aspirated and 200 µl of 
DMSO added and incubated for 10 minutes. Once complete, this solution was gently mixed before reading the 
absorbance at 540 nm in an ELx800 plate reading spectrophotometer (Bio-Tek, Wolf Laboratories, York, UK). 
Initial attached cell number in each well was determined by the absorbance.
In vitro cell migration assay (wound healing assay). Conventional wound healing scratch assays were 
also used to explore cellular migration rates and were undertaken using an EVOS® FL Auto Imaging System (Life 
Technologies, CA, USA) equipped with an EVOS® Onstage Incubator (Life Technologies, CA, USA). Cells were 
prepared in a 24-well plate and grown to form a monolayer before inducing a wound by scratching a 200 µl pipette 
tip through the monolayer. Following induction of the wound, the monolayer was washed, fresh medium added 
and cells allowed to recover for 10 minutes before placing the plate in an EVOS® Onstage Incubator pre-set to 
37 °C, 5% CO2 and 80% humidity. Image captures were programmed to three separate areas of each wound and 
each location was imaged at 1 hour intervals, for up to 20 hours. Wound healing scratch assay experiments involv-
ing treatments were undertaken using conventional image capture methodologies using an inverted microscope 
over 2 hour time points for an 8 hour period. Images of the scratch wound were taken at the same area over the 
time course and multiple regions of wound closure were quantiied within this area. For both methodologies, the 
distance between the two wound edges was measured using Image J, in pixels, and the distance change at every 
time interval was calculated through subtraction of the distance between each wound edge at each time point 
from the wound edge distance at time zero.
Tubule formation assay. A Matrigel tubule formation assay was used to assess the angiogenic potential of 
human endothelial cells following SOCS-3 and SOCS-4 manipulation. his methodology was adapted from a 
previously described method45. In brief, 50 µl of Matrigel matrix was gently pipetted into the bottom of each well 
in 96-well plate and incubated until polymerisation had occurred. Subsequently, cells were seeded onto the gel 
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at a density of 40,000 cells/well and the plate was incubated at 37 °C, 5% CO2 and 95% humidity. he plate was 
removed from the incubator and images were captured using a Leica DMi1 microscope equipped with a MC120 
HD camera and Leica Application Suite version 3.0.0 sotware (Leica Microsystems, Milton Keynes, UK) at the 
10th hour. he total perimeter of each formed tubule in every image was measured using Image J.
Kinexus protein microarray. Cells were grown to approximately 80% conluence in T75 tissue culture 
lasks. Cells were subsequently washed in PBS, scraped from the lasks using a sterile cell scraper and centrifuged 
to obtain a pellet. Subsequently the pellet was lysed in lysis bufer, transferred to a 1.5 ml eppendorf and placed 
on a rotating wheel for 40 minutes at 4 °C. Following this, insolubles were removed through centrifugation at 
13,000 rpm and the supernatant separated and quantiied using a Fluorescamine (Sigma-Aldrich, Dorset, UK) 
based luorescent assay, measured using a GloMax – Multi Microplate Multimode Reader (Promega Biosystems 
Inc., Sunnyvale, CA, USA). Samples were subsequently standardised and sent to Kinexus Bioinformatics, 
Vancouver, Canada, for protein microarray analysis using a KAM-880 array. Comparisons between HaCaT pEF6 
control protein and HaCaT SOCS-4 knockdown protein were drawn to yield percentage change from control 
(%CFC) and Z-ratio values.
Statistical analysis. Statistical analysis was undertaken using the SigmaPlot 11 and Graphpad Prism 6 sta-
tistical sotware packages. Data was analysed using t-test or Mann Whitney test, depending on data parameters. 
Internal replicates were set up within each experiment and each experiment was repeated independently at least 
three times. Values of p < 0.05 (*), p < 0.01 (**), p < 0.001 (***) and p < 0.0001 (****) were regarded as statis-
tically signiicant.
Data availability statement. he data supporting the indings of this study are available from the corre-
sponding author on reasonable request.
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